Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Respiratory Research|May 18, 2022
MAIT cell counts are associated with the risk of hospitalization in COPDTerezia Pincikova, Tiphaine Parrot, Lena Hjelte, et al.Pediatric Pulmonology|July 31, 2010
Gender differences in the Scandinavian cystic fibrosis populationHanne Vebert Olesen, Tacjana Pressler, Lena Hjelte, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2008
Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methodsTacjana Pressler, Ferenc Karpati, Marta Granström, et al.Therapeutic Advances in Respiratory Disease|May 23, 2024
Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in SwedenMahasin Al Shakirchi, Kimmo Sorjonen, Lena Hjelte, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Measurement of halide efflux from cultured and primary airway epithelial cells using fluorescence indicatorsFelix Munkonge, Eric W F W Alton, Charlotte Andersson, et al.Food & Nutrition Research|November 24, 2011
Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendationsInger E Moen, Kristina Nilsson, Anna Andersson, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 12, 2013
Nasal potential difference measurements in diagnosis of cystic fibrosis: an international surveyLutz Naehrlich, Manfred Ballmann, Jane Davies, et al.Iscience|September 26, 2022
Coxsackievirus B infections are common in Cystic Fibrosis and experimental evidence supports protection by vaccinationVirginia M Stone, Renata Utorova, Marta Butrym, et al.The Journal of Infectious Diseases|October 3, 2017
A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral DefenseEmma Svedin, Renata Utorova, Michael H Hühn, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2025
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosisNatalie E West, Michael W Konstan, Patrick A Flume, et al.Pageof 4